Skip to menu Skip to content Skip to footer
Professor Denise Doolan
Professor

Denise Doolan

Email: 
Phone: 
+61 7 334 62159

Overview

Background

Professor Denise Doolan is Director of Research at the Institute for Molecular Bioscience. She joined IMB in 2022 and was previously Deputy Director of the Australian Institute of Tropical Health and Medicine, and Director of the JCU Centre for Molecular Therapeutics, at James Cook University.

She is a molecular immunologist, working on the development of vaccines, diagnostics and host-directed therapeutics for infectious and chronic diseases that impact global public health, with a particular focus on malaria. Her cross-disciplinary research program spans host-pathogen immunity, antigen discovery, vaccine engineering, and biomarker discovery. A particular interest is the application of state-of-the-art genome-based technologies and human models of disease system to identify novel targets for intervention against disease or that predict risk of disease.

She is a recognized world expert in malaria immunology, vaccinology, and omic-based approaches for therapeutic and diagnostic development. She has been honoured as a Fellow of the International Society for Vaccines (2017) and a Fellow of the Australian Society of Parasitology (2019) in recognition of her leadership and contribution to health and medical science in Australia and internationally.

Professor Doolan serves on a number of Executive Boards and Advisory Boards. Most recently, she has been elected as President of the International Society for Vaccines (2021-2023), and has been appointed to the Federal Government’s Australian Medical Research Advisory Board (AMRAB; 2021-2026) to provide specialist insights into Australia’s medical research and innovation priorities.

Availability

Professor Denise Doolan is:
Available for supervision

Fields of research

Qualifications

  • Bachelor of Science, The University of Queensland
  • B Sc Hons (Biochemistry), The University of Queensland
  • M Phil (Life Sciences), Griffith University
  • PhD (Molecular Immunology), The University of Queensland

Works

Search Professor Denise Doolan’s works on UQ eSpace

219 works between 1987 and 2024

21 - 40 of 219 works

2021

Journal Article

Coronavirus Disease (COVID-19): Pathophysiology, epidemiology, clinical management and public health response

Doolan, Denise L., Kozlakidis, Zisis, Zhang, Zhongheng, Paessler, Slobodan, Su, Longxiang, Yokota, Yasuko Tsunetsugu, Shioda, Tatsuo, Rodriguez-Palacios, Alexander, Kaynar, Ata Murat, Ahmed, Rukhsana, Samy, Abdallah, Bradby, Hannah, Kalergis, Alexis M., Dutta, Mohan Jyoti, Kogut, Michael and Zhang, Shen-Ying (2021). Coronavirus Disease (COVID-19): Pathophysiology, epidemiology, clinical management and public health response. Frontiers in Public Health, 9 807159, 1-2. doi: 10.3389/fpubh.2021.807159

Coronavirus Disease (COVID-19): Pathophysiology, epidemiology, clinical management and public health response

2021

Journal Article

Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study

Pearson, Mark S., Tedla, Bemnet A., Mekonnen, Gebeyaw G., Proietti, Carla, Becker, Luke, Nakajima, Rie, Jasinskas, Al, Doolan, Denise L., Amoah, Abena S., Knopp, Stefanie, Rollinson, David, Ali, Said M., Kabole, Fatma, Hokke, Cornelis H., Adegnika, Akim A., Field, Matt A., van Dam, Govert, Corstjens, Paul L. A. M., Mduluza, Takafira, Mutapi, Francisca, Oeuvray, Claude, Greco, Beatrice, Chaiyadet, Sujittra, Laha, Thewarach, Cai, Pengfei, McManus, Donald P., Bottazzi, Maria Elena, Felgner, Philip L., Sotillo, Javier and Loukas, Alex (2021). Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study. The Lancet Microbe, 2 (11), E617-E626. doi: 10.1016/s2666-5247(21)00150-6

Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study

2021

Journal Article

Estimating the global burden of Epstein–Barr virus-related cancers

Wong, Yide, Meehan, Michael T., Burrows, Scott R., Doolan, Denise L. and Miles, John J. (2021). Estimating the global burden of Epstein–Barr virus-related cancers. Journal of Cancer Research and Clinical Oncology, 148 (1), 31-46. doi: 10.1007/s00432-021-03824-y

Estimating the global burden of Epstein–Barr virus-related cancers

2021

Journal Article

Identification of the Glycan binding profile of human and rodent Plasmodium sporozoites

Poole, Jessica, Hartley-Tassell, Lauren E., Day, Christopher J., Stanisic, Danielle, Groves, Penny L., Chakravarty, Sumana, Sim, B. Kim Lee, Hoffman, Stephen L., Tiralongo, Joe, Bovin, Nicolai, Doolan, Denise L. and Jennings, Michael P. (2021). Identification of the Glycan binding profile of human and rodent Plasmodium sporozoites. ACS Infectious Diseases, 7 (8), 2383-2389. doi: 10.1021/acsinfecdis.1c00084

Identification of the Glycan binding profile of human and rodent Plasmodium sporozoites

2021

Journal Article

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

Nguyen, Thi H. O., Rowntree, Louise C., Petersen, Jan, Chua, Brendon Y., Hensen, Luca, Kedzierski, Lukasz, van de Sandt, Carolien E., Chaurasia, Priyanka, Tan, Hyon-Xhi, Habel, Jennifer R., Zhang, Wuji, Allen, Lilith F., Earnest, Linda, Mak, Kai Yan, Juno, Jennifer A., Wragg, Kathleen, Mordant, Francesca L., Amanat, Fatima, Krammer, Florian, Mifsud, Nicole A., Doolan, Denise L., Flanagan, Katie L., Sonda, Sabrina, Kaur, Jasveen, Wakim, Linda M., Westall, Glen P., James, Fiona, Mouhtouris, Effie, Gordon, Claire L. ... Kedzierska, Katherine (2021). CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity, 54 (5), 1066-1082+. doi: 10.1016/j.immuni.2021.04.009

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

2021

Journal Article

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

Koutsakos, Marios, Rowntree, Louise C., Hensen, Luca, Chua, Brendon Y., van de Sandt, Carolien E., Habel, Jennifer R., Zhang, Wuji, Jia, Xiaoxiao, Kedzierski, Lukasz, Ashhurst, Thomas M., Putri, Givanna H., Marsh-Wakefield, Felix, Read, Mark N., Edwards, Davis N., Clemens, E. Bridie, Wong, Chinn Yi, Mordant, Francesca L., Juno, Jennifer A., Amanat, Fatima, Audsley, Jennifer, Holmes, Natasha E., Gordon, Claire L., Smibert, Olivia C., Trubiano, Jason A., Hughes, Carly M., Catton, Mike, Denholm, Justin T., Tong, Steven Y. C., Doolan, Denise L. ... Kedzierska, Katherine (2021). Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Reports Medicine, 2 (3) 100208, 1-21. doi: 10.1016/j.xcrm.2021.100208

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

2021

Journal Article

Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features

Rowntree, Louise C., Chua, Brendon Y., Nicholson, Suellen, Koutsakos, Marios, Hensen, Luca, Douros, Celia, Selva, Kevin, Mordant, Francesca L., Wong, Chinn Yi, Habel, Jennifer R., Zhang, Wuji, Jia, Xiaoxiao, Allen, Lily, Doolan, Denise L., Jackson, David C., Wheatley, Adam K., Kent, Stephen J., Amanat, Fatima, Krammer, Florian, Subbarao, Kanta, Cheng, Allen C., Chung, Amy W., Catton, Mike, Nguyen, Thi H. O., van de Sandt, Carolien E. and Kedzierska, Katherine (2021). Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features. Clinical and Translational Immunology, 10 (3) e1258, 1-18. doi: 10.1002/cti2.1258

Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features

2021

Journal Article

A dual-antigen enzyme-linked immunosorbent assay allows the assessment of severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in a low-transmission setting

Hicks, Sarah M., Pohl, Kai, Neeman, Teresa, McNamara, Hayley A., Parsons, Kate M., He, Jin-shu, Ali, Sidra A., Nazir, Samina, Rowntree, Louise C., Nguyen, Thi H. O., Kedzierska, Katherine, Doolan, Denise L., Vinuesa, Carola G., Cook, Matthew C., Coatsworth, Nicholas, Myles, Paul S., Kurth, Florian, Sander, Leif E., Mann, Graham J., Gruen, Russell L., George, Amee J., Gardiner, Elizabeth E. and Cockburn, Ian A. (2021). A dual-antigen enzyme-linked immunosorbent assay allows the assessment of severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in a low-transmission setting. Journal of Infectious Diseases, 223 (1), 10-14. doi: 10.1093/infdis/jiaa623

A dual-antigen enzyme-linked immunosorbent assay allows the assessment of severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in a low-transmission setting

2021

Journal Article

Memory CD8+ T cell compartment associated with delayed onset of Plasmodium falciparum infection and better parasite control in sickle-cell trait children

Loiseau, Claire, Traore, Boubacar, Ongoiba, Aissata, Kayentao, Kassoum, Doumbo, Safiatou, Doumtabe, Didier, de Sousa, Karina P., Brady, Jamie L., Proietti, Carla, Crompton, Peter D. and Doolan, Denise L. (2021). Memory CD8+ T cell compartment associated with delayed onset of Plasmodium falciparum infection and better parasite control in sickle-cell trait children. Clinical and Translational Immunology, 10 (3) e1265, 1-12. doi: 10.1002/cti2.1265

Memory CD8+ T cell compartment associated with delayed onset of Plasmodium falciparum infection and better parasite control in sickle-cell trait children

2020

Journal Article

Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8+ T Cell Responses but Differ in Capacity to Induce CD4+ T Cell Responses and Antibody Responses

Pattinson, David J., Apte, Simon H., Wibowo, Nani, Rivera-Hernandez, Tania, Groves, Penny L., Middelberg, Anton P. J. and Doolan, Denise L. (2020). Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8+ T Cell Responses but Differ in Capacity to Induce CD4+ T Cell Responses and Antibody Responses. Frontiers in Immunology, 11 564627, 1-13. doi: 10.3389/fimmu.2020.564627

Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8+ T Cell Responses but Differ in Capacity to Induce CD4+ T Cell Responses and Antibody Responses

2020

Journal Article

Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype

Habel, Jennifer R., Nguyen, Thi H. O., van de Sandt, Carolien E., Juno, Jennifer A., Chaurasia, Priyanka, Wragg, Kathleen, Koutsakos, Marios, Hensen, Luca, Jia, Xiaoxiao, Chua, Brendon, Zhang, Wuji, Tan, Hyon-Xhi, Flanagan, Katie L., Doolan, Denise L., Torresi, Joseph, Chen, Weisan, Wakim, Linda M., Cheng, Allen C., Doherty, Peter C., Petersen, Jan, Rossjohn, Jamie, Wheatley, Adam K., Kent, Stephen J., Rowntree, Louise C. and Kedzierska, Katherine (2020). Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype. Proceedings of the National Academy of Sciences of the United States of America, 117 (39), 24384-24391. doi: 10.1073/pnas.2015486117

Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype

2020

Journal Article

Uptake of Schistosoma mansoni extracellular vesicles by human endothelial and monocytic cell lines and impact on vascular endothelial cell gene expression

Kifle, Desalegn Woldeyohannes, Chaiyadet, Sujittra, Waardenberg, Ashley J., Wise, Ingrid, Cooper, Martha, Becker, Luke, Doolan, Denise L., Laha, Thewarach, Sotillo, Javier, Pearson, Mark S. and Loukas, Alex (2020). Uptake of Schistosoma mansoni extracellular vesicles by human endothelial and monocytic cell lines and impact on vascular endothelial cell gene expression. International Journal for Parasitology, 50 (9), 685-696. doi: 10.1016/j.ijpara.2020.05.005

Uptake of Schistosoma mansoni extracellular vesicles by human endothelial and monocytic cell lines and impact on vascular endothelial cell gene expression

2020

Journal Article

Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma

Liu, Zhiwei, Jarrett, Ruth F, Hjalgrim, Henrik, Proietti, Carla, Chang, Ellen T., Smedby, Karin E., Yu, Kelly J., Lake, Annette, Troy, Sally, McAulay, Karen A., Pfeiffer, Ruth M., Adami, Hans-Olov, Glimelius, Bengt, Melbye, Mads, Hildesheim, Allan, Doolan, Denise L. and Coghill, Anna E. (2020). Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma. International Journal of Cancer, 147 (3), 608-618. doi: 10.1002/ijc.32741

Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma

2020

Journal Article

Erratum: Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan (Clinical cancer research : an official journal of the American Association for Cancer Research (2018) 24 6 (1305-1314))

Coghill, Anna E., Pfeiffer, Ruth M., Proietti, Carla, Hsu, Wan-Lun, Chien, Yin-Chu, Lekieffre, Lea, Krause, Lutz, Teng, Andy, Pablo, Jocelyn, Yu, Kelly J., Lou, Pei-Jen, Wang, Cheng-Ping, Liu, Zhiwei, Chen, Chien-Jen, Middeldorp, Jaap, Mulvenna, Jason, Bethony, Jeff, Hildesheim, Allan and Doolan, Denise L. (2020). Erratum: Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan (Clinical cancer research : an official journal of the American Association for Cancer Research (2018) 24 6 (1305-1314)). Clinical Cancer Research, 26 (13), 3496-3496. doi: 10.1158/1078-0432.CCR-20-1828

Erratum: Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan (Clinical cancer research : an official journal of the American Association for Cancer Research (2018) 24 6 (1305-1314))

2020

Journal Article

Development and validation of serological markers for detecting recent Plasmodium vivax infection

Longley, Rhea J., White, Michael T., Takashima, Eizo, Brewster, Jessica, Morita, Masayuki, Harbers, Matthias, Obadia, Thomas, Robinson, Leanne J., Matsuura, Fumie, Liu, Zoe S. J., Li-Wai-Suen, Connie S. N., Tham, Wai-Hong, Healer, Julie, Huon, Christele, Chitnis, Chetan E., Nguitragool, Wang, Monteiro, Wuelton, Proietti, Carla, Doolan, Denise L., Siqueira, Andre M., Ding, Xavier C., Gonzalez, Iveth J., Kazura, James, Lacerda, Marcus, Sattabongkot, Jetsumon, Tsuboi, Takafumi and Mueller, Ivo (2020). Development and validation of serological markers for detecting recent Plasmodium vivax infection. Nature Medicine, 26 (5), 741-749+. doi: 10.1038/s41591-020-0841-4

Development and validation of serological markers for detecting recent Plasmodium vivax infection

2020

Journal Article

Validation of an Epstein-Barr virus antibody risk stratification signature for nasopharyngeal carcinoma by use of multiplex serology

Simon, Julia, Liu, Zhiwei, Brenner, Nicole, Yu, Kelly J., Hsu, Wan-Lun, Wang, Cheng-Ping, Chien, Yin-Chu, Coghill, Anna E., Chen, Chien-Jen, Butt, Julia, Proietti, Carla, Doolan, Denise L., Hildesheim, Allan and Waterboer, Tim (2020). Validation of an Epstein-Barr virus antibody risk stratification signature for nasopharyngeal carcinoma by use of multiplex serology. Journal of Clinical Microbiology, 58 (5) e00077-20, 1-9. doi: 10.1128/JCM.00077-20

Validation of an Epstein-Barr virus antibody risk stratification signature for nasopharyngeal carcinoma by use of multiplex serology

2020

Journal Article

A novel population of memory‐activated natural killer cells associated with low parasitaemia in Plasmodium falciparum ‐exposed sickle‐cell trait children

Loiseau, Claire, Doumbo, Ogobara K., Traore, Boubacar, Brady, Jamie L., Proietti, Carla, Sousa, Karina P., Crompton, Peter D. and Doolan, Denise L. (2020). A novel population of memory‐activated natural killer cells associated with low parasitaemia in Plasmodium falciparum ‐exposed sickle‐cell trait children. Clinical and Translational Immunology, 9 (4) e1125, e1125. doi: 10.1002/cti2.1125

A novel population of memory‐activated natural killer cells associated with low parasitaemia in Plasmodium falciparum ‐exposed sickle‐cell trait children

2020

Journal Article

An analytically and diagnostically sensitive RNA extraction and RT-qPCR protocol for peripheral blood mononuclear cells

Browne, Daniel J., Brady, Jamie L., Waardenberg, Ashley J., Loiseau, Claire and Doolan, Denise L. (2020). An analytically and diagnostically sensitive RNA extraction and RT-qPCR protocol for peripheral blood mononuclear cells. Frontiers in Immunology, 11 402, 1-15. doi: 10.3389/fimmu.2020.00402

An analytically and diagnostically sensitive RNA extraction and RT-qPCR protocol for peripheral blood mononuclear cells

2020

Journal Article

The rise of non-tuberculosis mycobacterial lung disease

Ratnatunga, Champa N., Lutzky, Viviana P., Kupz, Andreas, Doolan, Denise L., Reid, David W., Field, Matthew, Bell, Scott C., Thomson, Rachel M. and Miles, John J. (2020). The rise of non-tuberculosis mycobacterial lung disease. Frontiers in Immunology, 11 303, 303. doi: 10.3389/fimmu.2020.00303

The rise of non-tuberculosis mycobacterial lung disease

2020

Journal Article

Deciphering host immunity to malaria using systems immunology

Loiseau, Claire, Cooper, Martha M. and Doolan, Denise L. (2020). Deciphering host immunity to malaria using systems immunology. Immunological Reviews, 293 (1), 115-143. doi: 10.1111/imr.12814

Deciphering host immunity to malaria using systems immunology

Funding

Current funding

  • 2024 - 2025
    Development of a multi-antigen T-cell malaria vaccine
    James Cook University
    Open grant
  • 2024 - 2026
    Effective Multiple Sclerosis diagnosis based on EBV proteome screening
    MS Research Australia Project Grant
    Open grant
  • 2023 - 2025
    Human-informed data-driven development of next-generation T cell vaccine against malaria
    United States National Institutes of Health
    Open grant

Past funding

  • 2013 - 2017
    Tropical disease - immunity, pathogenesis and vaccine development: global translation (NHMRC Program Grant administered by Griffith University)
    Griffith University
    Open grant
  • 2012 - 2014
    ResTeach Funding 2012 0.1 FTE School of Medicine/School of Chemisty and Molecular Biosciences
    UQ ResTeach
    Open grant

Supervision

Availability

Professor Denise Doolan is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • UNDERSTANDING THE LINK BETWEEN EBV AND MULTIPLE SCLEROSIS

    An opportunity exists for a PhD position in molecular immunology, where cutting-edge technologies will be applied to understand the molecular basis of the link between EBV and Multiple Sclerosis. Epstein-Barr virus (EBV) is the top identified causative agent of Multiple Sclerosis, but how this occurs is not known. This project aims to apply an innovative approach using proteome-wide screening of EBV to identify the subset of EBV proteins from the complete EBV proteome that triggers MS. It will compare responses in individuals with different stages of MS and apply sophisticated computational analytics to identify specific EBV proteins that predict MS disease. This EBV signature of MS could be translated into a clinic-friendly point-of-care test. If successful, this project could revolutionize the diagnosis and management of MS, providing patients with a quicker and more accurate diagnosis and enhanced quality of life.

    Subject areas: Immunology, Molecular immunology, Systems biology, Multiple Sclerosis, Autoimmunity, EBV

    Eligibility: Entry: Bachelor degree with Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: laboratory-based experience in immunology, host-pathogen interactions, immune regulation and infectious diseases; excellent computer, communication, and organisational skills are required.

    Supervisors:

    Professor Denise Doolan & Dr Carla Proietti

  • MOLECULAR IMMUNOLOGY OF MALARIA

    An opportunity exists for a PhD position in the molecular immunology of malaria. The focus of this project will be to apply cutting-edge technologies to understand the molecular basis of protective immunity to malaria. It will take advantage of controlled human infection models and as well as animal models to explore the mechanisms underlying protective immunity to malaria and immune responsiveness. Using a range of interdisciplinary approaches, including immune profiling, transcriptomics, proteomics, and small molecule characterization, the project aims to define the critical cells and signalling pathways required for protective immunity against malaria. It is anticipated that this research will have broad application to a wide range of infectious and chronic diseases, with important implications for vaccination.

    Subject areas: Immunology, Molecular immunology, Systems biology, Vaccinology, Malaria

    Eligibility: Entry: Bachelor degree with Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: laboratory-based experience in immunology, host-pathogen interactions, immune regulation and infectious diseases; excellent computer, communication, and organisational skills are required.

    Supervisors:

    Professor Denise Doolan (IMB) & Dr Carla Proietti (IMB)

  • VACCINE ENGINEERING

    An opportunity exists for a PhD position in vaccine engineering. Vaccines are one of the most effective health care interventions but remain a challenge for many diseases, and in particular intracellular pathogens such as malaria where T cell responses are particularly desirable. We have been exploring novel approaches to rationally design an effective vaccine against challenging disease targets. By taking advantage of recent advances in genomic sequencing, proteomics, transcriptional profiling, and molecular immunology, we have discovered unique targets of T cell responses or antibody response. This project will test these antigens as vaccine candidates by assessing immunogenicity, protective capacity and biological function using different vaccine platforms. By designing an effective vaccine from genomic data, this project is expected to result in significance advances in vaccinology as well as immunology, with important public health outcomes.

    Subject areas: Immunology, Vaccinology, Molecular immunology, Malaria, Vaccine engineering, Vaccine design

    Eligibility: Entry: Bachelor degree with Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: laboratory-based experience in immunology, host-pathogen interactions, immune regulation and infectious diseases; excellent computer, communication, and organisational skills are required.

    Supervisor:

    Professor Denise Doolan (IMB) & Professor Carla Proietti (IMB)

  • SYSTEMS IMMUNOLOGY AND MULTI-OMICS APPROACHES TO UNDERSTAND PROTECTIVE IMMUNITY TO HUMAN MALARIA

    This PhD project aims to develop and apply computational approaches that integrate systems biology and molecular immunology to understand host-pathogen immunity and predict immune control of malaria. The project will utilise systems-based immunology and multi-omics approaches to profile the host immune response in controlled infection models of malaria at molecular, cellular, transcriptome and proteome-wide scale.

    The overall aim will be to develop and apply omics-based technologies and computational tools, including network theory and machine learning, to integrate multiple high-dimensional datasets and reveal novel insights into host-pathogen immunity and predict immune responsiveness and parasite control. Modelling of large-scale existing datasets, including those generated by single-cell RNA-sequencing technologies, may also be a feature of this project. The opportunity to identify new knowledge and integrate this with experimental data produced by our laboratory will be instrumental to extending the impact of these bioinformatics analyses. This project will provide an opportunity to be at the forefront in cutting-edge technologies and advances in computational analysis of integrated high-dimensional omic data.

    Methodologies: Bioinformatics, Machine Learning, Immunology, Systems Immunology, Systems Biology, Genomics/Proteomics/Transcriptomics, Molecular and Cell Biology, Statistics

    Eligibility: Entry: BSc Honours Class I (or equivalent via outstanding record of professional or research achievements) Experience/Background: Experience with programming languages, mathematics, statistics and/or background in immunology and molecular sciences, with an interest in integrating the fields of immunology and bioinformatics.

    Excellent computer, communication, and organisational skills are required. Forward thinking, innovation and creativity are encouraged.

    Supervisors:

    Professor Denise Doolan (IMB) & Dr Carla Proietti (IMB)

    Associate Professor Jessica Mar (AIBN)

Supervision history

Current supervision

  • Doctor Philosophy

    Understanding the Molecular Basis of Immune Heterogeneity using Systems Immunology

    Principal Advisor

  • Doctor Philosophy

    Systems immunology and multi-omics approaches to understand protective immunity to human malaria

    Principal Advisor

Completed supervision

Media

Enquiries

For media enquiries about Professor Denise Doolan's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au